By 2025, GLP-1 injections have become a "super target" in the global pharmaceutical industry
Policy discussions also consider indirect economic benefits
Drug-specific monitoring schedule | Drug | Monitoring parameter | Timing after GLP-1 start | |---|---|---| | Warfarin | INR | 2 weeks, 4 weeks, then per standard | | Levothyroxine | TSH | 6 to 8 weeks | | Cyclosporine/tacrolimus | Trough level | Weekly for first 8 weeks | | Oral contraceptive | Add barrier method | For first 4+ weeks per Ozempic label | | Digoxin | Serum digoxin, ECG if symptomatic | 4 weeks | | Lithium | Serum lithium | 2 to 4 weeks, especially if nausea reduces fluid intake | What the Clinical Trial Data Actually Show Most large GLP-1 outcome trials were not designed to measure drug-drug interactions, but pharmacokinetic sub-studies and post-marketing data fill some gaps
U-100 refers to the unit marking format used on many insulin syringe listings
La science derrire le produit: La L-cystine est un acide amin essentiel, un des trois acides amins qui contiennent du soufre
ME/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature